Search Within

Azeez Farooki

Formats
  1. Journal Article (40)
  2. Meeting Abstract (24)
  3. Review (5)
  4. Book Section (3)
  5. Guidelines (3)
  6. Conference Paper (1)
Groups
  1. Department of Medicine (76)
  2. Division of Subspecialty Medicine (76)
  3. Endocrinology (76)
  4. Survivorship Research (76)
  5. Solid Tumor Oncology Division (27)
  6. Breast Medicine Service (15)

More Groups

People
  1. Monica Fornier (14)
  2. Cherry Estilo (7)
  3. Michael Morris (7)
  4. Joseph Huryn (6)
  5. Aaron Mitchell (5)
  6. Monica Girotra (5)

More People

Years
  1. 2024 (4)
  2. 2023 (5)
  3. 2022 (7)
  4. 2021 (5)
  5. 2020 (7)
  6. 2019 (7)

More Years

Publications
  1. Journal of Clinical Oncology (14)
  2. Annals of Oncology (5)
  3. Endocrine Practice (3)
  4. Contemporary Endocrinology (2)
  5. Biology of Blood and Marrow Transplantation (2)
  6. Clinical Lymphoma, Myeloma and Leukemia (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (15)
  2. Oxford University Press (9)
  3. Elsevier Inc. (8)
  4. Springer (6)
  5. Wiley Blackwell (5)
  6. American Association of Clinical Endocrinologists (3)

More Publishers

Results (76)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Targeting insulin feedback to enhance alpelisib (TIFA): A phase II randomized trial in metastatic, PIK3CA-mutant, hormone receptor-positive breast cancer
    Meeting Abstract

    Shen, S.; Salehi, E.; Farooki, A.; Flory, J.; Williams, D.; Carpio, A.; Chang, C.; Lacouture, M. E.; Andreopoulou, E.; Sardesai, S. D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • EPIK-B4: A phase 2, randomized study of metformin (MET) extended release (XR) +/- dapagliflozin (DAPA) to prevent hyperglycemia (HG) in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), PIK3CA-mutated (mut) advanced breast cancer (ABC) treated with alpelisib (ALP) and fulvestrant (FUL)
    Meeting Abstract

    Gradishar, W. J.; Farooki, A.; Giridhar, K.; Moore, H.; Johnston, A.; Miller, M. K.; Wang, C.; Reising, A.; O'Shaughnessy, J.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Expert consensus recommendations for managing hyperglycemia and rash in patients with PIK3CA -mutated, hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2–) advanced breast cancer (ABC) treated with alpelisib (ALP)
    Meeting Abstract

    Gallagher, E. J.; Moore, H.; Lacouture, M. E.; Dent, S. F.; Farooki, A.; Goncalves, M. D.; Isaacs, C.; Johnston, A.; Juric, D.; Quandt, Z.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Use of bone modifying agents for metastatic castrate-resistant prostate cancer
    Meeting Abstract

    Mitchell, A. P.; Mishra Meza, A.; Farooki, A.; Panageas, K.; Bach, P. B.; Lipitz-Snyderman, A.; Morris, M. J.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Overview of hypercalcemia of malignancy and humoral hypercalcemia of malignancy
    Journal Article

    Farooki, A.
    Contemporary Endocrinology (2022)

    Fulltext@MSK | Save
  • Management of phosphatidylinositol-3-kinase inhibitor-associated hyperglycemia
    Journal Article

    Goncalves, M. D.; Farooki, A.
    Integrative Cancer Therapies (2022)

    Fulltext@MSK | Save
  • Hypercalcemic crisis
    Book Section

    Chukir, T.; Farooki, A.; Bilezikian, J. P. Endocrine Emergencies (2021)

    Fulltext@MSK | Save
  • Vertebral fractures after denosumab discontinuation in breast cancer survivors: A single institution experience
    Review

    Yeung, M.; Ho, K.; Fornier, M. N.; Farooki, A.
    HSS Journal (2021)

    Fulltext@MSK | Save
  • A risk analysis of alpelisib (ALP)-induced hyperglycemia (HG) using baseline factors in patients (pts) with advanced solid tumours and breast cancer (BC): A pooled analysis of X2101 and SOLAR-1
    Meeting Abstract

    Rodon, J.; Demanse, D.; Rugo, H. S.; Andre, F.; Janku, F.; Mayer, I.; Burris, H.; Simo, R.; Farooki, A.; Hu, H.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Bone mineral density: Clinical relevance and quantitative assessment
    Review

    Haseltine, K. N.; Chukir, T.; Smith, P. J.; Jacob, J. T.; Bilezikian, J. P.; Farooki, A.
    Journal of Nuclear Medicine (2021)

    Fulltext@MSK | Save